JPWO2021220140A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021220140A5
JPWO2021220140A5 JP2022565551A JP2022565551A JPWO2021220140A5 JP WO2021220140 A5 JPWO2021220140 A5 JP WO2021220140A5 JP 2022565551 A JP2022565551 A JP 2022565551A JP 2022565551 A JP2022565551 A JP 2022565551A JP WO2021220140 A5 JPWO2021220140 A5 JP WO2021220140A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
jia
pediatric patient
tnf antibody
weeks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022565551A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524668A (ja
JP2023524668A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/053429 external-priority patent/WO2021220140A1/en
Publication of JP2023524668A publication Critical patent/JP2023524668A/ja
Publication of JPWO2021220140A5 publication Critical patent/JPWO2021220140A5/ja
Publication of JP2023524668A5 publication Critical patent/JP2023524668A5/ja
Pending legal-status Critical Current

Links

JP2022565551A 2020-04-27 2021-04-26 若年性特発性関節炎を治療するための材料及び方法 Pending JP2023524668A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063015902P 2020-04-27 2020-04-27
US202063015889P 2020-04-27 2020-04-27
US202063015894P 2020-04-27 2020-04-27
US63/015,902 2020-04-27
US63/015,894 2020-04-27
US63/015,889 2020-04-27
PCT/IB2021/053429 WO2021220140A1 (en) 2020-04-27 2021-04-26 Materials and methods for treating juvenile idiopathic arthritis

Publications (3)

Publication Number Publication Date
JP2023524668A JP2023524668A (ja) 2023-06-13
JPWO2021220140A5 true JPWO2021220140A5 (https=) 2024-05-01
JP2023524668A5 JP2023524668A5 (https=) 2024-05-01

Family

ID=78336251

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565551A Pending JP2023524668A (ja) 2020-04-27 2021-04-26 若年性特発性関節炎を治療するための材料及び方法

Country Status (9)

Country Link
EP (1) EP4143226A4 (https=)
JP (1) JP2023524668A (https=)
KR (1) KR20230005284A (https=)
CN (1) CN115461365A (https=)
AU (1) AU2021263136A1 (https=)
BR (1) BR112022021766A2 (https=)
CA (1) CA3127807A1 (https=)
IL (1) IL297623A (https=)
MX (1) MX2022013502A (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102961746B (zh) * 2005-05-16 2016-06-15 艾伯维生物技术有限公司 TNFα抑制剂治疗腐蚀性多关节炎的用途
US10465003B2 (en) * 2016-02-05 2019-11-05 Janssen Biotech, Inc. Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
KR20190113858A (ko) * 2017-01-30 2019-10-08 얀센 바이오테크 인코포레이티드 활성 건선성 관절염의 치료를 위한 항-tnf 항체, 조성물, 및 방법

Similar Documents

Publication Publication Date Title
Krain et al. Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid
Steere et al. Treatment of the early manifestations of Lyme disease
KLINE et al. Further studies on: one day treatment of depression with 5-Htp
US20010026801A1 (en) Cytokine antagonists for the treatment of localized disorders
JP2024170522A5 (https=)
CN105228622B (zh) 用于治疗多发性硬化的PPARγ激动剂
JPS63502591A (ja) リユ−マチ様関節炎の治療のための方法と物質
Helmchen et al. Effect of 3, 4-diaminopyridine on the gravity dependence of ocular drift in downbeat nystagmus
US6384083B1 (en) Use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with bdv infections in humans and animals
US4887995A (en) Method of treating sickle cell anemia
JPWO2021220140A5 (https=)
JP2021522241A5 (https=)
McKay et al. Infliximab-Induced Improvement in Dercum's Disease
JPWO2022117799A5 (https=)
JPWO2020148651A5 (https=)
CN1282241A (zh) 局部麻醉剂抗血管性头痛的新用途
JPWO2020160465A5 (https=)
Berlin et al. Plasma exchange in endocrine ophthalmopathy
JPS631295B2 (https=)
JPWO2020245676A5 (https=)
JPWO2022093724A5 (https=)
JPH0251405B2 (https=)
WO2024217522A1 (zh) 一种异噻唑并[5,4-d]嘧啶类化合物治疗炎性疾病的用途
HK40123216A (zh) 一种治疗多发性硬化症的方法
Gilmore et al. Controlled trial of cyclophosphamide in active chronic hepatitis